These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3434325)

  • 61. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE; Kraus M
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.
    Cameron OG; Smith CB; Hollingsworth PJ; Nesse RM; Curtis GC
    Arch Gen Psychiatry; 1984 Dec; 41(12):1144-8. PubMed ID: 6095785
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
    Mavissakalian M; Perel J; Bowler K; Dealy R
    Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Panic disorder and panic attack].
    Abbar M
    Encephale; 1996 Dec; 22 Spec No 5():13-8. PubMed ID: 9138941
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fears.
    Drenckhan I; Glöckner-Rist A; Rist F; Richter J; Gloster AT; Fehm L; Lang T; Alpers GW; Hamm AO; Fydrich T; Kircher T; Arolt V; Deckert J; Ströhle A; Wittchen HU; Gerlach AL
    Psychol Med; 2015 Jun; 45(8):1675-85. PubMed ID: 25482960
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Depression with panic attacks: clinical characteristics and prevalence in hospital].
    Hardy P; Feline A; De Bonis M; Rigaud AS; Epelbaum C
    Can J Psychiatry; 1990 Mar; 35(2):170-4. PubMed ID: 2317748
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thyroid indices in panic disorder.
    Fishman SM; Sheehan DV; Carr DB
    J Clin Psychiatry; 1985 Oct; 46(10):432-3. PubMed ID: 4044534
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
    Noyes R; Garvey MJ; Cook BL; Samuelson L
    J Clin Psychiatry; 1989 May; 50(5):163-9. PubMed ID: 2715139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks.
    Faravelli C; Webb T; Ambonetti A; Fonnesu F; Sessarego A
    Am J Psychiatry; 1985 Dec; 142(12):1493-4. PubMed ID: 4073319
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alprazolam in the treatment of panic disorders.
    Liebowitz MR; Fyer AJ; Gorman JM; Campeas R; Levin A; Davies SR; Goetz D; Klein DF
    J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A prospective study of panic and anxiety in agoraphobia with panic disorder.
    Başoğlu M; Marks IM; Sengün S
    Br J Psychiatry; 1992 Jan; 160():57-64. PubMed ID: 1347481
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of agoraphobia and panic attacks.
    Matuzas W; Glass RM
    Arch Gen Psychiatry; 1983 Feb; 40(2):220-2. PubMed ID: 6824417
    [No Abstract]   [Full Text] [Related]  

  • 74. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
    Pecknold JC; Luthe L; Iny L; Ramdoyal D
    J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The sequence of panic symptoms.
    Katerndahl DA
    J Fam Pract; 1988 Jan; 26(1):49-52. PubMed ID: 3339305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of efficacy of carbamazepine in the treatment of panic disorder.
    Uhde TW; Stein MB; Post RM
    Am J Psychiatry; 1988 Sep; 145(9):1104-9. PubMed ID: 3046381
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. One-year follow-up of cardiac anxiety syndromes. Outcome and predictors of course.
    Maier W; Buller R; Frommberger U; Philipp M
    Eur Arch Psychiatry Neurol Sci; 1987; 237(1):16-20. PubMed ID: 3428312
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Self-esteem, life stress and psychiatric disorder.
    Miller PM; Kreitman NB; Ingham JG; Sashidharan SP
    J Affect Disord; 1989; 17(1):65-75. PubMed ID: 2525578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of people with infrequent panic attacks.
    Norton GR; Harrison B; Hauch J; Rhodes L
    J Abnorm Psychol; 1985 May; 94(2):216-21. PubMed ID: 3998290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.